1.  
1983 Khan M, Islam N, Rahman KM.
Atypical Presentation of Amoebic Liver Abscess (Abstract).
Hepatology 1983; 3(6): 1065A
  1.  
1984 Khan M, Islam N, Islam MN.
Outlook of Fulminant Hepatic Failure with Conventional Management.
International Association for the Study of the Liver (Abstract Booklet) 1984:63
  1.  
1985 Khan M, Islam N.
Primary Carcinoma of Liver.
Indian Medical Gazette 1985 CXIX (4):122.
  1.  
1986 Khan M, Murphy T, Halliday JW, Cooksley WGE, Robert R, Powell LW.
Caffeine Pharmacokinetics as a Quantitative Liver Function Test with Particular Reference to Prognosis (Abstract). Hepatology 1986; 6(4):787
  1.  
1993 Khan M, Zaki KMJ, Hossain SMN, Saha KP, Ali SM.
Clinical Profile and Natural Course of Subacute Hepatic Failure.
International Symposium on Viral Hepatitis and Liver Disease, Tokyo (Abstract Volume) 1993.
  1.  
1994 Khan M, Kiyosawa K, Ahmad N, et al.
HCV Seroprevalence in Liver Disease in Bangladesh.
9th Biennial Scientific Meeting of APASL, Kuala Lumpur (Abstract Volume) 1994: 128.
  1.  
1994 Khan M, Rahman S, Ahmad N, Zaki KMJ, Hoque HW.
Subacute Hepatic Failure: Clinical Course and Outcome.
6th National Convention, Association of Physicians of Bangladesh, Dhaka, 1994 (Abst. Vol.)
  1.  
1995 Khan M, Ahmad N, Rahman S, Hoque HW.
Diphenyl Dimethyl Dicarboxylate (PMC) in Chronic Viral B Hepatitis.
3rd Annual Convention, Bangladesh Gastroenterology Society, Dhaka, 1995 (Abst. Vol.).
  1.  
1995 Khan M, Rahman S, Ahmad N, Matin MA, Hoque HW.
Experience on the Effect of Phyllanthrus Amarus on Chronic HBsAg Carriers.
3rd Annual Convention, Bangladesh Gastroenterology Society, Dhaka, 1995 (Abst. Vol.).
  1.  
1995 Khan M.
End Stage Liver Disease : Therapeutic Option (Bangladesh Perspective).
UST Manual 1995, University of Science & Technology, Chittagong, 1995; 30-32.
  1.  
1995 Khan M, Ahmad N, Rahman S, Matin MA, Zaki KMJ, Hoque HW.
Acute Sporadic Viral Hepatitis E in Bangladesh.
First International Conference on Hepatitis E Virus, New Delhi. 1995 (Abstract Volume).
  1.  
1995 Morshed SA, Parveen S, Nishioka M, Kawanishi K, Kinoshita M, Khan M.
Hepatitis B Virus Pre-core Mutation and Serotypes in Patients with Chronic and Fulminant Hepatitis in Bangladesh (Abst.). Hepatology 1995; 22 (Suppl. 4): 460A
  1.  
1995 Khan M, Ahmad N.
Subacute Hepatic Failure.
6th World Congress of International Gastro-Surgical Club, Bangkok, Thailand 1995 (Abst. Vol.); p52
  1.  
1996 Khan M, Ahmad N, Rahman S, Matin MA, Zaki KMJ, Hoque HW.
Hydatid Disease of Liver : A study of 20 Cases.
10th Biennial Scientific Meeting, APASL, Rawalpindi, Pakistan (Abstract Volume) 1996; p62.
  1.  
1997 Khan M, Ahmad N, Rahman S, Hossain MM, Zaki KHJ.
Acute Viral Hepatitis E : Clinical Course.
Hepatology 1997; 26 (4/2) Supplement: 1230A
  1.  
2001 Khan M. Uddin N.  Management of Cirrhotic Ascites. .
 4th JSH International Symposium on Liver Cirrhosis and Liver Cancer, Shimonoseki, Yamaguchi, Japan 2001(Abstract); p23
  1.  
2002 Khan M, Alam.K, Rahman S, Azam MG, Ahmad N. .
Response to Lamivudine Therapy in Chronic Hepatitis B patients in Bangladesh. .
Journal of Hepatology 2002 ; 36 (Suppl.1)
  1.  
2002 Khan M, Alam K, Rahman S, Azam MG, Ahamed MK, Ahmad N.
Seroprevalence and management of hepatitis B in Bangladesh.
Journal of Gastroenterology and Hepatology 2002 ; 17 (Suppl- September).
  1.  
2003 Alam K, Rahman S, Ahmad N, Azam MG and Khan M.
Peginterferon a-2a alone or in combination with ribavirin in chronic hepatitis C patients in Bangladesh.
The Indonesian J Gastro, Hepatol and Digest Endoscopy 2003;4(suppl 1):s17. [Abstract]
  1.  
2006 Karim MF, Rahman S, Zaki KMJ and Khan M.
Serum interleukin-10 level in patients with chronic hepatitis B infection.
 J Gastroenterol and Hepatol 2006;21(suppl 1):A28 (Abstract)
  1.  
2006 Khan M, Azam MG, Alam K, Rahman S and Ahmad N.
Treatment of chronic hepatitis B in Bangladesh.
J Gastroenterol and Hepatol 2006;21(suppl 1):A31 (Abstract)
  1.  
2006 Alam S, Khan M, Alam K, Rahman S, Ahmad N and Karim F.
Hepatobiliary and pancreatic ascariasis: presentations and endoscopic management.
 J Gastroenterol and Hepatol 2006;21(suppl 1):A58 (Abstract)
  1.  
2006 Mahtab M, Rahman S & Khan M.
HBeAg-negative chronic hepatitis B results in more severe liver disease than HBeAg-Positive chronic hepatitis B.
Liver International 2006. (Abstract)
  1.  
2006 Mahtab M, Khan M, Alam K, Rahman S, Ahmad N, Mamun A & Karim F.
Hepatitis E virus is a leading cause of decompensation of liver in cirrhotic patients in Bangladesh
Liver International 2006. (Abstract)
  1.  
2006 Mahtab M, Kumar SI, Rahman S, Khan M, Aggarwal R and Afroz S.
Correlation between HBV genotype and wild type and pre-core/ core promoter mutant HBV in Bangladeshi CHB patients.
Ind J Gastroenterol 2006;25(2):LV21(abstract)
  1.  
2007 Mahtab M, Rahman S, Khan M and Kamal M.
Pre-core/Core promoter mutant hepatitis B virus produces more severe histologic liver disease than wild-type hepatitis B virus.
11th ASCON Dhaka, 4-6 March, 2007. (Abstract)
  1.  
2007 Mahtab M, Afroz S, Rahman S and Khan M.
Hepatitis E virus is the leading cause of acute viral hepatitis in Bangladeshi pregnant women.
Hepatol Int 2007;1(1):p26 (Abstract)
  1.  
2007 Mahtab M, Afroz S, Rahman S and Khan M.
Spectrum of Hepatitis E virus infection in Bangladesh.
Hepatol Int 2007;1(1):p26 (Abstract)
  1.  
2007 Mahtab M, Afroz S, Rahman S and Khan M.
Hepatitis E virus is the leading cause of fulminant hepatic failure in Bangladesh.
Hepatol Int 2007;1(1):p40 (Abstract)
  1.  
2007 Rashid H, Alam S, Ahmad N, Khan M et al.
Effect of large volume paracentesis without albumin on renal function in cirrhotic ascites.
Hepatol Int 2007;1(1):p45 (Abstract)
  1.  
2007 Mahtab M, Kumar SI, Kamal M, Khan M et al
Hepatitis B virus genotypes in Bangladesh.
Hepatol Int 2007;1(1):p105 (Abstract)
  1.  
2007 Afroz S, Mahtab M, Rahman S and Khan M.
Hepatitis B virus is the leading cause of cirrhosis of liver in Bangladesh.
Hepatol Int 2007;1(1):p120 (Abstract)
  1.  
2007 Azam MG, Alam K, Ahmad N and Khan M.
Treatment of Hepatitis B e antigen-negative chronic hepatitis B patients in Bangladesh.
Hepatol Int 2007;1(1):p125 (Abstract)
  1.  
2007 Azam MG, Ahmad N and Khan M.
Seroprevalence and characteristics of HBe-antigen negative chronic hepatitis B patients.
Hepatol Int 2007;1(1):p129 (Abstract)
  1.  
2007 Alam S, Ahmad N, Mostofa G, Mamun AA, Mashud G and Khan M.
Seroprevalence of hepatitis C virus in health care workers of Bangladesh.
Hepatol Int 2007;1(1):p141 (Abstract)
  1.  
2007 Alam S, Ahmad N, Mostofa G and Khan M.
Patients profile of non alcoholic fatty liver disease of Bangladesh..
Hepatol Int 2007;1(1):p222 (Abstract)
  1.  
2007 Alam S, Mostofa G, Ahmad N, Khan M et al.
Study of complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis.
Hepatol Int 2007;1(1):p234 (Abstract)
  1.  
2007 Mahtab MA, Rahman S, Khan M, Ahmed F and Podder PK.
Aetiology of chronic hepatitis in Bangladesh.
Indian Journal of Gastroenterology 2007;26(2):A142
  1.  
2007 Mahtab MA, Rahman S, Khan M, Ahmed F and Podder PK.
Aetiology of SOL of liver in Bangladesh.
Indian Journal of Gastroenterology 2007;26(2):A76
  1.  
2007 Mahtab MA, Rahman S, Khan M, Hussain MF.
Medicine specialists are less susceptible to HCV infection compared to other health care personnel in Bangladesh.
Indian Journal of Gastroenterology 2007;26(2):A67
  1.  
2007 Mahtab MA, Rahman S, Khan M, Kamal M and Hussain MF.
Ultrasonography as tool for detecting NAFLD: Experience from a tertiary centre in Bangladesh.
Diabetes and Endocrine Journal 2007;36(1):A30.
  1.  
2007 Mahtab MA, Rahman S, Khan M, Kamal M and Mamun AA.
HBeAg negative chronic hepatitis B with persistently normal serum transaminase and low HBV DNA can cause significant liver disease.
Indian Journal of Gastroenterology 2007;26:297 (Letter)
  1.  
2008 Alam S, Ahmad N, Mustafa G and Khan M.
Etiology and predictors of outcome of fulminant hepatic failure: Hepatitis E virus is the leading cause.
Hepatol Int 2008;2(1):p128 (Abstract)
  1.  
2008 Alam S, Ahmad N, Mustafa G and Khan M.
Not only obesity but over-weight is also a risk factor for non-alcoholic fatty liver disease.
Hepatol Int 2008;2(1):p154 (Abstract)
  1.  
2008 Alam S, Rahman S, Mustafa G and Khan M.v
Biliary ascariasis with dead worm is far more dangerous than alive one.
Hepatol Int 2008;2(1):p197 (Abstract)
  1.  
2008 Azam MG, Khan M, Alam K, Rahman S and Ahmad N.
Genotype distribution of hepatitis C virus in Bangladesh.
Hepatol Int 2008;2(1):p260 (Abstract)
  1.  
2008 Azam MG and Khan M.
Efficacy and safety of peginterferon alpha-2a in chronic hepatitis C.
Hepatol Int 2008;2(1):p269 (Abstract)
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, Mamun AA and Islam MB.
APRI is not a useful predictor of fibrosis in CHB.
Journal of Hepatology 2008;48(2):S247.
  1.  
2008 Mahtab M, Kumar SI, Rahman S, Kamal M, Khan M and Aggarwal.
Hepatitis B virus genotypes and their consequences in Bangladesh. 
26th National Convention 2008, Bangladesh Society of Pathologists, Dhaka, June 21, 2008. (Abstract)
  1.  
2008 Mahtab MA, Rahman S, Khan M, Akbar SMF, Kamal M, et al.
High HBV DNA load, HBeAg positivity and consideable hepatic necroinflammation in patients with incidentally detected, asymptomatic chronic HBV-infected individuals from Bangladesh.
Hepatology 2008;48(4):690A. (Abstract)
  1.  
2008 Mahtab MA, Rahman S, Khan M, Akbar SMF, Kamal M, et al.
Lack of correlation between viral load and extent of liver damages in patients with chronic hepatitis HBV infection at Bangladesh.
Hepatology 2008;48(4):690A. (Abstract)
  1.  
2008 Rahman S, Mahtab MA, Khan M et al.
Hepatitis E virus is the leading cause for ACLF: Experience from a tertiary centre in Bnagladesh.
Joint conference of BCPS and CPSP 2008;October 20-23
  1.  
2008 Rahman S, Mahtab MA, Khan M et al.
Profile of NAFLD: Experience from a tertiary centre in Bangladesh.
Joint conference of BCPS and CPSP 2008;October 20-23
  1.  
2008 Rashid H-O, Alam S, Khan M et al.
Large volume paracentesis without albumin infusion causes no renal impairment in child’s grade C cirrhotic patients.
J Gatroenterol Hepatol 2008;23(suppl.51):A74
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Serum AST is a better predictor of necroinflammation then serum ALT in patients with wild type CHB: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A26
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Serum ALT is a better predictor of necroinflammation then serum AST in patients with pre-core mutant type CHB: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A27
  1.  
2008 Mahtab MA, Rahman S, Khan M et al.
HBeAg positive CHB is associated with higher HBV DNA than HBeAg negative CHB.
J Gatroenterol Hepatol 2008;23(suppl.51):A27
  1.  
2008 Mahtab MA, Rahman S, Khan M et al.
HBeAg positive HBV produces more severe liver disease than HBeAg negative CHB.
J Gatroenterol Hepatol 2008;23(suppl.51):A27
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Genotypes of HCV in Bnagladesh: experience from a tertiary center.
J Gatroenterol Hepatol 2008;23(suppl.51):A27
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Prevalence of HBeAg negative HBV infection in Bnagladeshi IDHAS.
J Gatroenterol Hepatol 2008;23(suppl.51):A28
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Insulin resistance is not frequently associated with nonalcoholic steatohepatitis: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A47
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Insulin sensitivity index is superior to insulin resistance in predicting NASH. 
J Gatroenterol Hepatol 2008;23(suppl.51):A47
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Prevalence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A47
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Serum ALT level poorly correlates with necroinflammation and fibrosis i patients with NAFLD: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A47
  1.  
2008 Mahtab MA, Rahman S, Khan M, Kamal M, et al.
Serum ALT is a better predictor of fibrosis than serum AST in patients with NAFLD: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A45
  1.  
2008 Mahtab MA, Rahman S, Khan M et al.
Aetiology of drug induced hepatitis: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A46
  1.  
2008 Mahtab MA, Rahman S, Khan M et al.
Aetiology of non-alcoholic steatohepatitis: experience from a tertiary centre in Bangladesh.
J Gatroenterol Hepatol 2008;23(suppl.51):A45
  1.  
2009 M.Mahtab, S. Rahman, K.Khan et al.
Immune Clearance State of HBV Infection : Time to Redefine?
Hepatol Int 2009;3(1):A101.
  1.  
2009 M. Mahtab, S. Rahman, M.Khan et al.
Comparison between HBeAg Positive and HBeAg Negative Chronic Hepatitis B in Young Bangladeshis: Experience from a Tertiary Centre.
Hepatol Int 2009;3(1):A102.
  1.  
2009 M. Mahtab, S. Rahman, M. Khan et al.
Profile HBeAg+ve Chronic HBV Infection in Bangladesh.
Hepatol Int 2009;3(1):A102
  1.  
2009 M. Mahtab, S. Rahman, M. Khan et al.
High viral Load Does Not Necessarily Represent Significant Liver Damage in Patients with Chronic HBV Infection in Bangladesh.
Hepatol Int 2009;3(1):A102.
  1.  
2009 M. Mahtab, S. Rahman, M. Khan et al.
Characteristics of Patients with NAFLD in Bangladesh.
Hepatol Int 2009;3(1):A190.
  1.  
2009 M. Mahtab, S. Rahman, M. Khan et al.
Aetiology of HCC in Bangladesh.
Hepatol Int 2009;3(1):A140.
  1.  
2009 M. Mahtab, S. Rahman, M. Khan et al.
Aetiology of acute hepatitis in pregnant women in the third trimester: Experience from a tertiary hospital in Bangladesh.
7th SAFOG March 06-08, 2009 (Abstract)
  1.  
2010 Khan M,  Azam MG,  Alam S  et al.
Management of chronic hepatitis with oral antiviral agents: Experience from Bangladesh. Hepatol Int 2010;4(suppl 1):p S99 [Abstract]
  1.  
2010 Azam MG,  Khan M,  Alam S  et al.
Lamivudine for chronic hepatitis B virus infection: efficacy and drug resistance during long-term treatment. Hepatol Int 2010;4(1):p 135 [Abstract]
  1.  
2010 Azam MG,  Khan M,  Alam S  et al. 
Peginterferon alfa-2b (12 KD) in chronic hepatitis B patients in Bangladesh: A preliminary study. Hepatol Int 2010;4(1):p 137 [Abstract]
  1.  
2010 Azam MG,  Khan M,  Alam S  et al. 
Telbivudine in chronic hepatitis B: One-year result among Bangladeshi patients. Hepatol Int 2010;4(1):p 141 [Abstract]
  1.  
2011 Azam MG,  Khan M,  Alam S  et al.  
Telbivudine for chronic hepatitis B Bangladeshi patients: Interim analysis of 365 cases. Hepatol Int 2011;5(1):p 116 [Abstract]
  1.  
2011 Azam MG,  Khan M,  Alam S  et al.  Telbivudine versus lamivudine for chronic hepatitis B patients in Bangladesh: Results at 1 year. Hepatol Int 2011;5(1):p 139 [Abstract]
  1.  
2011 Azam MG, Khan M, Ahmad N et al.  Peginterferon alpha-2a in chronic hepatitis C Bangladeshi patients treated for 24 weeks irrespective of genotypes: Results of 112 cases. Hepatol Int 2011;5(1):p 252 [Abstract]
  1.  
2012 Khan M, Azam MG, Alam S et al. Efficacy and safety of prolonged 3-year lamivudine treatment in patient with chronic hepatitis B in Bangladesh. Hepatol Int 2012;6(1):p 114 [Abstract]
  1.  
2012 Khan M, Azam MG, Alam S et al. Entecavir for chronic hepatitis B Bangladeshi patients: Interim analysis of 644 cases. Hepatol Int 2012;6(1):p 115 [Abstract]
  1.  
2012 Azam MG,  Khan M,  Uddin A  et al.  Efficacy of 52 weeks treatment with entecavir vs adefovir for chronic hepatitis B in Bangladesh. Hepatol Int 2012;6(1):p 126 [Abstract]
  1.  
2012 Khan M,  Azam MG,  Uddin A  et al.  Efficacy of switching to entecavir in chronic hepatitis B patients treated previously with lamivudine. Hepatol Int 2012;6(1):p 126 [Abstract]
  1.  
2012 Azam MG,  Khan M,  Abdullah S  et al.  Telbivudine and entecavir for adult chronic hepatitis B patients in Bangladesh: Results at 1 year. Hepatol Int 2012;6(1):p 127 [Abstract]
  1.  
2012 Khan M,  Azam MG,  Abdullah S  et al.  Spectrum of liver disease in Bangladesh:Change over a decade. Hepatol Int 2012;6(1):p 268 [Abstract]
  1.  
2013 Azam MG, Khan M,  Rahman A et al. Hepatitis C virus and diabetes: the dilemma confounding the relationship with each other in an observational study. Hepatol Int 2013;7(1):p 365 [Abstract]
  1.  
2013 Khan M,  Azam MG,  Jahan SMS  et al.  Efficacy of 52 weeks treatment with entecavir vs tenofovir for chronic hepatitis B in Bangladesh. Hepatol Int 2013;7(1):p 276 [Abstract]
  1.  
2013 Azam MG,  Khan M,  Abdullah S  et al.  Treatment of chronic hepatitis B with entecavir in ‘real-life’ settings: 2 years experience from a tertiary care centre in Dhaka. Hepatol Int 2013;7(1):p 230 [Abstract]  
  1.  
2013 Khan M and Azam MG. Telbivudine for the treatment of decompensated hepatitis B virus-related cirrhosis in Bangladesh. Hepatol Int 2013;7(1):p 185 [Abstract]
  1.  
2013 Azam MG and Khan M. Real-life experience of telbivudine among chronic hepatitis B: 2 years observation from a tertiary care centre in Dhaka. Hepatol Int 2013;7(1):p 270 [Abstract]  
  1.  
2014 Mohammad Golam Azam and Mobin Khan. Efficacy and safety of prolonged 3-year entecavir treatment in patients with chronic hepatitis B in Bangladesh:  a ‘Real life’ experience. Hepatol Int (2014) 8:S55 [Abstract]  
  1.  
2014 Mobin Khan and Mohammad Golam Azam. Efficacy of entecavir among chronic hepatitis B patients previously treated with peginterferon alpha 2a: new option of sequential therapy in a developing country. Hepatol Int (2014) 8:S54 [Abstract]  
  1.  
2014 Mohammad Golam Azam and Mobin Khan. Efficacy of telbivudine among chronic hepatitis B patients previously treated with peginterferon alpha 2a for a short
period. Hepatol Int (2014) 8:S55 [Abstract]  
  1.  
2014 Mobin Khan and Mohammad Golam Azam. Tenofovir ameliorates viral rebound
in chronic hepatitis B patients previously treated with telbivudine: a single centre experience. Hepatol Int (2014) 8:S56 [Abstract]